Direct-to-consumer pharmacies could save commercially insured patients 85% on high-cost generic drugs
American College of Physicians (ACP)
A report comparing the Mark Cuban Cost Plus Drug Company (MCCPDC) to copayments or coinsurance under employer-sponsored insurance found that patients with high-cost generic prescriptions could lower their out-of-pocket costs from $140 to $25 by bypassing their insurance and using MCCPDC.